<code id='4E3F2F228D'></code><style id='4E3F2F228D'></style>
    • <acronym id='4E3F2F228D'></acronym>
      <center id='4E3F2F228D'><center id='4E3F2F228D'><tfoot id='4E3F2F228D'></tfoot></center><abbr id='4E3F2F228D'><dir id='4E3F2F228D'><tfoot id='4E3F2F228D'></tfoot><noframes id='4E3F2F228D'>

    • <optgroup id='4E3F2F228D'><strike id='4E3F2F228D'><sup id='4E3F2F228D'></sup></strike><code id='4E3F2F228D'></code></optgroup>
        1. <b id='4E3F2F228D'><label id='4E3F2F228D'><select id='4E3F2F228D'><dt id='4E3F2F228D'><span id='4E3F2F228D'></span></dt></select></label></b><u id='4E3F2F228D'></u>
          <i id='4E3F2F228D'><strike id='4E3F2F228D'><tt id='4E3F2F228D'><pre id='4E3F2F228D'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:44954
          A man, who is suffering from frostbite, displays his hands. -- health coverage from STAT
          Jon Cherry/Getty Images

          Two days after his right hand froze, Hart Bezner realized for the first time that he might lose it.

          The retired physics professor was sitting in an emergency room in Whitehorse, the capital of Canada’s Yukon territory, where two doctors and a pharmacist were taking an unusual amount of interest in the appendage and the pink blisters that now covered it. 

          advertisement

          “Will I lose my hand?” he remembers asking. “Will this go away?”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Latigo launches with $135 million for Vertex

          DesmondPadhi,PharmD,interimCEO,Latigo(center),withLatigoboardchairNancyStagliano(left)andWestlakeVil